ARVN Stock Analysis: Buy, Sell, or Hold?
ARVN - Arvinas, Inc
$10.10
-0.77 (-7.08%)
▼
5d:
-7.68%
30d:
-24.51%
90d:
-16.32%
HOLD
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 07, 2026
Smart Money Accumulation
ARVN is down 17.8% this week, but smart money is accumulating calls. Top strike: $14 2026-04-17 with 574 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When ARVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARVN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ARVN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ARVN is currently trading at $10.10, which is considered oversold relative to its 30-day fair value range of $11.11 to $13.49.
Technical Outlook: Technically, ARVN is in a uptrend. The price is currently testing key support at $9.96. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.1% recently.
Market Sentiment: ARVN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $14.88 (+47.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARVN is in a uptrend. The price is currently testing key support at $9.96. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.1% recently.
Market Sentiment: ARVN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $14.88 (+47.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$11.11 -
$13.49
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.5%
Protect Your Profits
Holding ARVN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.1%)
- BULLISH: Trading 47.3% below Wall St target ($14.88)
- CAUTION: Recommendation downgraded due to -7.7% 5-day decline
Fair Price Analysis
30-Day Fair Range
$11.11 -
$13.49
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.97
(9.6%)
Support & Resistance Levels
Support Level
$9.96
Resistance Level
$12.50
Current Trend
Uptrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.87
Wall Street Target
$14.88
(+47.3%)
Revenue Growth (YoY)
-84.0%
Profit Margin
-30.8%
Share & Embed Analysis
Last updated: March 30, 2026 8:56 AM ET
Data refreshes hourly during market hours. Next update: 9:56 AM
Data refreshes hourly during market hours. Next update: 9:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARVN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Briggs Morrison
BUY
20000 shares
2026-03-06
John G Houston
SELL
35297 shares
2026-02-27
David K Loomis
SELL
1108 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 65 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 49 HOLD |
Advanced ARVN Option Strategies
Professional options setups generated by AI based on today's ARVN price and gamma walls.
